Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that a conference call to discuss the Q2FY21 and H1FY21 financial results will be held on Friday, 06th November, 2020 at 05.30 P.M. Please find attached herewith the conference call details. Kindly take note of the same Alkem Laboratories Ltd - 539523 - Board Meeting Intimation for Notice Of Meeting Of The Board Of Directors Of The Company Scheduled To Be Held On 06Th November, 2020.
Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2020 ,inter alia, to consider and approve the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter ended 30th September, 2020. Kindly take note of the same. Alkem Laboratories Ltd - 539523 - Compliances- Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended 30Th September, 2020.
In terms of Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Certificate received from Practising Company Secretary for the half year ended 30th September, 2020. Kindly take the same on record. Alkem Laboratories Ltd - 539523 - Shareholding for the Period Ended September 30, 2020
Alkem Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click here Alkem Laboratories Ltd - 539523 - Statement Of Investor Complaints For The Quarter Ended September 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Manish NarangDesignation :- Company Secretary and Compliance Officer Alkem Laboratories Ltd - 539523 - Compliances- Compliance Certificate For The Period Ended September, 2020.
With reference to the subject matter, please find enclosed herewith the Compliance Certificate under Regulation 7(3) SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, duly signed by the Compliance officer and the authorised representative of Link Intime India Pvt Ltd (RTA) for the half year ended 30th September, 2020. Kindly take the same on your records. Alkem Laboratories Ltd - 539523 - Closure of Trading Window
This is to inform you that in terms of Company''s Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the trading window will remain closed from 29th September, 2020 until the expiry of 48 hours after the date on which the Financial Results of the Company for the quarter and half ended 30th September, 2020 are communicated to the Stock Exchanges. Double-digit sales dip in anti-infective segment to weigh on Alkem Labs
Higher chronic sales, US market could offset some of the weakness in sales growth Alkem Laboratories Ltd - 539523 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Alkem Laboratories Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Alkem Laboratories Ltd - 539523 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
This is with reference to the 46th Annual General Meeting ('AGM') of the Company held on Tuesday, 18th August, 2020 at 11.00 a.m. through Video Conferencing (VC)/ Other Audio Visual Means (OAVM). Please find enclosed herewith the details regarding the voting results of the business transacted at the said AGM in the prescribed format and the Report of the Scrutinizer on remote e-voting and e-voting during the AGM. You are requested to take a note of the same.